Posted by Michael Wonder on 22 May 2023
The role of disclosures: helping to understand oncology clinical trial endpoints
18 May 2023 - FDA researchers wanted to see whether consumers understand oncology endpoints in DTC television ads, and whether disclosures can help people distinguish among overall survival, overall response rate, and progression-free survival.
To that end, FDA researchers conducted two studies that examined a television ad for fictional prescription oncology drugs: Xedaliti for lung cancer and Vulpafen for multiple myeloma.
